Literature DB >> 32130883

Bacteria Boost Mammalian Host NAD Metabolism by Engaging the Deamidated Biosynthesis Pathway.

Igor Shats1, Jason G Williams2, Juan Liu3, Mikhail V Makarov4, Xiaoyue Wu5, Fred B Lih2, Leesa J Deterding2, Chaemin Lim6, Xiaojiang Xu7, Thomas A Randall7, Ethan Lee8, Wenling Li9, Wei Fan8, Jian-Liang Li7, Marina Sokolsky6, Alexander V Kabanov6, Leping Li9, Marie E Migaud4, Jason W Locasale3, Xiaoling Li10.   

Abstract

Nicotinamide adenine dinucleotide (NAD), a cofactor for hundreds of metabolic reactions in all cell types, plays an essential role in metabolism, DNA repair, and aging. However, how NAD metabolism is impacted by the environment remains unclear. Here, we report an unexpected trans-kingdom cooperation between bacteria and mammalian cells wherein bacteria contribute to host NAD biosynthesis. Bacteria confer resistance to inhibitors of NAMPT, the rate-limiting enzyme in the amidated NAD salvage pathway, in cancer cells and xenograft tumors. Mechanistically, a microbial nicotinamidase (PncA) that converts nicotinamide to nicotinic acid, a precursor in the alternative deamidated NAD salvage pathway, is necessary and sufficient for this protective effect. Using stable isotope tracing and microbiota-depleted mice, we demonstrate that this bacteria-mediated deamidation contributes substantially to the NAD-boosting effect of oral nicotinamide and nicotinamide riboside supplementation in several tissues. Collectively, our findings reveal an important role of bacteria-enabled deamidated pathway in host NAD metabolism. Published by Elsevier Inc.

Entities:  

Keywords:  NAMPT inhibitors; cancer cells; deamidated NAD synthesis; germ-free mice; host-microbe interaction; microbial nicotinamidase; mycoplasma; nicotinic acid; oral nicotinamide riboside supplementation

Year:  2020        PMID: 32130883      PMCID: PMC7194078          DOI: 10.1016/j.cmet.2020.02.001

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  48 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications.

Authors:  Bo Tan; Debra A Young; Zhao-Hai Lu; Tao Wang; Timothy I Meier; Robert L Shepard; Kenneth Roth; Yan Zhai; Karen Huss; Ming-Shang Kuo; James Gillig; Saravanan Parthasarathy; Timothy P Burkholder; Michele C Smith; Sandaruwan Geeganage; Genshi Zhao
Journal:  J Biol Chem       Date:  2012-12-13       Impact factor: 5.157

Review 3.  NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus.

Authors:  Carles Cantó; Keir J Menzies; Johan Auwerx
Journal:  Cell Metab       Date:  2015-06-25       Impact factor: 27.287

Review 4.  NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism.

Authors:  Wusheng Xiao; Rui-Sheng Wang; Diane E Handy; Joseph Loscalzo
Journal:  Antioxid Redox Signal       Date:  2017-07-28       Impact factor: 8.401

Review 5.  Molecular biology and pathogenicity of mycoplasmas.

Authors:  S Razin; D Yogev; Y Naot
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

6.  Association of Mycoplasma hominis infection with prostate cancer.

Authors:  Yulia A Barykova; Denis Yu Logunov; Maxim M Shmarov; Andrei Z Vinarov; Dmitry N Fiev; Natalia A Vinarova; Irina V Rakovskaya; Patricia Stanhope Baker; Inna Shyshynova; Andrew J Stephenson; Eric A Klein; Boris S Naroditsky; Alexander L Gintsburg; Andrei V Gudkov
Journal:  Oncotarget       Date:  2011-04

Review 7.  NAD Metabolism in Cancer Therapeutics.

Authors:  Keisuke Yaku; Keisuke Okabe; Keisuke Hikosaka; Takashi Nakagawa
Journal:  Front Oncol       Date:  2018-12-12       Impact factor: 6.244

8.  Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer.

Authors:  Jair Machado Espindola-Netto; Claudia C S Chini; Mariana Tarragó; Enfeng Wang; Shamit Dutta; Krishnendu Pal; Debabrata Mukhopadhyay; Mauro Sola-Penna; Eduardo N Chini
Journal:  Oncotarget       Date:  2017-06-29

9.  Nicotinamide mononucleotide (NMN) supplementation ameliorates the impact of maternal obesity in mice: comparison with exercise.

Authors:  Golam Mezbah Uddin; Neil A Youngson; Bronte M Doyle; David A Sinclair; Margaret J Morris
Journal:  Sci Rep       Date:  2017-11-08       Impact factor: 4.379

10.  The Pfam protein families database in 2019.

Authors:  Sara El-Gebali; Jaina Mistry; Alex Bateman; Sean R Eddy; Aurélien Luciani; Simon C Potter; Matloob Qureshi; Lorna J Richardson; Gustavo A Salazar; Alfredo Smart; Erik L L Sonnhammer; Layla Hirsh; Lisanna Paladin; Damiano Piovesan; Silvio C E Tosatto; Robert D Finn
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

View more
  49 in total

Review 1.  The CD38 glycohydrolase and the NAD sink: implications for pathological conditions.

Authors:  Julianna D Zeidler; Kelly A Hogan; Guillermo Agorrody; Thais R Peclat; Sonu Kashyap; Karina S Kanamori; Lilian Sales Gomez; Delaram Z Mazdeh; Gina M Warner; Katie L Thompson; Claudia C S Chini; Eduardo Nunes Chini
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-09       Impact factor: 4.249

2.  β-Nicotinamide Mononucleotide (NMN) Administrated by Intraperitoneal Injection Mediates Protection Against UVB-Induced Skin Damage in Mice.

Authors:  Xianrong Zhou; Hang-Hang Du; Xingyao Long; Yanni Pan; Jian Hu; Jianjun Yu; Xin Zhao
Journal:  J Inflamm Res       Date:  2021-10-07

3.  Tryptophan regulates bile and nitrogen metabolism in two pig gut lactobacilli species in vitro based on metabolomics study.

Authors:  Shizhe Wu; Moyan Liu; Hui Chen; Qingqing Song; Zhenlong Wu; Zhaolai Dai
Journal:  Amino Acids       Date:  2022-07-15       Impact factor: 3.789

Review 4.  NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential.

Authors:  Na Xie; Lu Zhang; Wei Gao; Canhua Huang; Peter Ernst Huber; Xiaobo Zhou; Changlong Li; Guobo Shen; Bingwen Zou
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

5.  Nicotinamide riboside-amino acid conjugates that are stable to purine nucleoside phosphorylase.

Authors:  Faisal Hayat; Marie E Migaud
Journal:  Org Biomol Chem       Date:  2020-04-15       Impact factor: 3.876

Review 6.  Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism.

Authors:  Ilaria Elia; Marcia C Haigis
Journal:  Nat Metab       Date:  2021-01-04

Review 7.  Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma.

Authors:  James R Tribble; Flora Hui; Melissa Jöe; Katharina Bell; Vicki Chrysostomou; Jonathan G Crowston; Pete A Williams
Journal:  Cells       Date:  2021-02-01       Impact factor: 6.600

Review 8.  Advances in NAD-Lowering Agents for Cancer Treatment.

Authors:  Moustafa S Ghanem; Fiammetta Monacelli; Alessio Nencioni
Journal:  Nutrients       Date:  2021-05-14       Impact factor: 5.717

Review 9.  NAD+ Metabolism, Metabolic Stress, and Infection.

Authors:  Benjamin Groth; Padmaja Venkatakrishnan; Su-Ju Lin
Journal:  Front Mol Biosci       Date:  2021-05-19

Review 10.  What We Know So Far about the Metabolite-Mediated Microbiota-Intestinal Immunity Dialogue and How to Hear the Sound of This Crosstalk.

Authors:  Clément Caffaratti; Caroline Plazy; Geoffroy Mery; Abdoul-Razak Tidjani; Federica Fiorini; Sarah Thiroux; Bertrand Toussaint; Dalil Hannani; Audrey Le Gouellec
Journal:  Metabolites       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.